TIVDAK

WIPO WIPO 2019

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The International trademark TIVDAK was filed as Word mark on 03/14/2019 at the World Intellectual Property Organization.

Trademark Details Last update: February 15, 2023

Trademark form Word mark
File reference 1463518A
Countries Armenia Australia Azerbaijan Bahrain Brunei Belarus Switzerland China Colombia Algeria Egypt Georgia Indonesia Israel India Iran Iceland Kyrgyzstan Cambodia South Korea Kazakhstan Laos Liechtenstein Moldova Mongolia Malaysia Norway New Zealand Oman Philippines Serbia Russia Singapore Thailand Tajikistan Turkmenistan Turkey Ukraine Uzbekistan Vietnam
Application date March 14, 2019
Expiration date March 14, 2029

Trademark owner

21823 30th Drive S.E.
Bothell WA 98021
US

Trademark representatives

379 Lytton Avenue Palo Alto CA 94301 US

goods and services

05 Pharmaceutical preparations for use in humans, namely, chemotherapeutics and biopharmaceuticals; pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, and the genitourinary system; pharmaceutical preparations for the treatment of cancer, autoimmune diseases, and inflammatory disorders; pharmaceutical preparations for use in dermatology, oncology, hematology, ophthalmology, gastroenterological disorders, and tissue and organ transplantology
42 Biotechnology research, namely, research and development of pharmaceutical preparations for use in humans; research and development of pharmaceutical preparations for the diagnosis, prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, and the genitourinary system; research and development of pharmaceutical preparations for the diagnosis, prevention and treatment of cancer, autoimmune diseases, inflammatory disorders, gastroenterological disorders and for use in dermatology, oncology, hematology, ophthalmology, and tissue and organ transplantation

Trademark history

Date Document number Area Entry
February 6, 2023 2023/7 Gaz LA Rejection
January 27, 2023 2023/6 Gaz TH Rejection
January 25, 2023 2023/4 Gaz MY Rejection
January 9, 2023 2023/2 Gaz TM Rejection
September 23, 2022 2022/40 Gaz TJ RAW: Rule 18ter(2)(i) GP following a provisional refusal
August 13, 2022 2022/33 Gaz ID Rejection
August 4, 2022 2022/31 Gaz LI Rejection
August 4, 2022 2022/31 Gaz VN Rejection
July 26, 2022 2022/30 Gaz GE Rejection
June 27, 2022 2022/26 Gaz MD Rejection
June 17, 2022 2022/25 Gaz AM Rejection
May 24, 2022 2022/23 Gaz TJ Rejection
April 26, 2022 2022/17 Gaz KZ Rejection
March 31, 2022 2022/13 Gaz KG Rejection
March 10, 2022 2022/12 Gaz MN Rejection
February 17, 2022 2022/8 Gaz RS Rejection
January 30, 2022 2022/5 Gaz DZ Rejection
December 31, 2021 2022/1 Gaz BY Rejection
November 23, 2021 2021/48 Gaz CO RAW: Rule 18ter(2)(i) GP following a provisional refusal
November 18, 2021 2021/46 Gaz NO Rejection
July 21, 2021 2021/29 Gaz Correction
December 23, 2020 2020/52 Gaz TR Rejection
December 10, 2020 2021/1 Gaz IL RAW: Rule 18ter(2)(ii) GP following a provisional refusal
April 17, 2020 2020/17 Gaz NO Rejection
April 17, 2020 2020/17 Gaz UA Rejection
March 20, 2020 2020/13 Gaz CH Rejection
March 11, 2020 2020/11 Gaz KR Rejection
November 19, 2019 2019/48 Gaz IL Rejection
November 18, 2019 2019/47 Gaz IN Rejection
November 15, 2019 2019/47 Gaz RU Rejection
October 22, 2019 2019/43 Gaz AU Rejection
October 17, 2019 2019/42 Gaz SG Rejection
September 17, 2019 2019/38 Gaz NZ Rejection
August 28, 2019 2019/36 Gaz CO Rejection
June 19, 2019 2019/25 Gaz CN Rejection

ID: 999914146351865